Evaluating the anxiety and depression status of prostate cancer patients whose operations were postponed because of the COVID-19 pandemic.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
17
12
2020
accepted:
26
04
2021
pubmed:
30
4
2021
medline:
24
7
2021
entrez:
29
4
2021
Statut:
ppublish
Résumé
In this study, we aimed to evaluate the anxiety and depression status of prostate cancer (PCa) patients whose planned operations in the urology clinic of our hospital, which is serving as a pandemic hospital in Turkey have been postponed because of the coronavirus disease 2019 pandemic. This survey study was conducted at urology clinic of Ankara City Hospital between March 1 and June 1, 2020, and included 24 male patients who agreed to answer the questionnaires (State-Trait Anxiety Inventory [STAI] I and II and Beck Depression Inventory [BDI]). Demographical and clinical data (age, time since diagnosis, total serum prostate-specific antigen (PSA) levels, risk groups according to the D'Amico classification system, smoking, alcohol habitus, major surgical history and comorbidities) of the patients were collected from hospital software. The mean STAI-I score of the patients (46.7 ± 1.4 [44-49]) was significantly higher than their STAI-II score (41.7 ± 2.4 [39-47]) (P < .001). The negative correlation between the decrease in age and STAI-I score was found to be statistically significant (r = 0.439, P < .05). The mean BDI score of the patients was 4.3 ± 3.2 (0-13), which was compatible with mild depression. There was no statistically significant difference among the time elapsed from diagnosis, PSA levels, smoking and alcohol habitus, major surgical history and comorbidity status and STAI-I, STAI-II and BDI scores (P > .05). Prostate cancer patients with postponed operations should be guided properly in order to manage their anxiety status especially young patients.
Identifiants
pubmed: 33914983
doi: 10.1111/ijcp.14278
pmc: PMC8236926
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14278Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Am J Clin Pathol. 2020 Mar 9;153(4):420-421
pubmed: 32053148
Int J Clin Pract. 2021 Aug;75(8):e14278
pubmed: 33914983
Int J Clin Oncol. 2016 Jun;21(3):595-600
pubmed: 26585896
JAMA. 1998 Sep 16;280(11):969-74
pubmed: 9749478
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137
Int Urol Nephrol. 2020 Nov;52(11):2059-2064
pubmed: 32583371
Eur Urol Focus. 2020 Sep 15;6(5):1097-1103
pubmed: 32534969
Br J Cancer. 2017 Mar 28;116(7):864-873
pubmed: 28222069
Behav Med. 2010 Jan-Mar;36(1):32-6
pubmed: 20185399
Eur Urol. 2020 Jun;77(6):663-666
pubmed: 32279903
Br J Clin Psychol. 1992 Sep;31(3):301-6
pubmed: 1393159
Am J Obstet Gynecol. 2020 Nov;223(5):725.e1-725.e9
pubmed: 32598911
J Clin Psychol. 2015 Sep;71(9):898-907
pubmed: 25950150
Cancer. 2005 Aug 1;104(3):467-78
pubmed: 15959911
Minerva Urol Nefrol. 2020 Jun;72(3):369-375
pubmed: 32202401
Asian Pac J Cancer Prev. 2015;16(6):2527-30
pubmed: 25824791